statement
CagriSema consists of the long-acting amylin receptor agonist cagrilintide and the GLP-1 receptor agonist semaglutide.
A statement by 界面新闻. Statements are as reported by the cited publishers — not verified by DecisionGateway.
由长效胰淀素受体激动剂卡瑞林肽和 GLP-1 受体激动剂司美格鲁肽组成